Sérgio Rizzo

Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib

Bruno Vincenzi, Daniele Santini, Antonio Russo et al. · The Oncologist · 2010 · 174 citations · Full text

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

Francesco Passiglia, Giuseppe Bronte, Viviana Bazan et al. · Oncotarget · 2016 · 165 citations · Full text

The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients

Francesco Pantano, P Berti, Francesco Maria Guida et al. · Journal of Cellular and Molecular Medicine · 2013 · 91 citations · Full text

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Sabino De Placido, Ciro Gallo, Michelino De Laurentiis et al. · The Lancet Oncology · 2018 · 86 citations · Full text

Endocrine Oncology, Breast Oncology, Medicine +7

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects

Giuseppe Bronte, Christian Rolfo, Elisa Giovannetti et al. · Critical Reviews in Oncology/Hematology · 2013 · 75 citations · Full text

Oncology, Medicine, Bronchial Neoplasm +7